James S Wilmott

James S Wilmott

Melanoma Institute Australia, The University of Sydney
在 sydney.edu.au 的电子邮件经过验证
被引用次数：43611
cancer cell biology molecular biology targeted therapies melanoma
Andrew M. Scott

Andrew M. Scott

Olivia Newton-John Cancer Research Institute, and Austin Health, Melbourne, Australia
在 onjcri.org.au 的电子邮件经过验证
被引用次数：32916
Cancer biology targeted therapies molecular imaging
Gerald Batist

Gerald Batist

Professor,McGill University
在 mcgill.ca 的电子邮件经过验证
被引用次数：23231
Pharmacology Targeted therapies
Klaus Podar

Klaus Podar

Karl Landsteiner Private University of Health Sciences
在 krems.lknoe.at 的电子邮件经过验证
被引用次数：22168
signal transduction apoptosis multiple myeloma targeted therapies microenvironment
Wassim Abida

Wassim Abida

Memorial Sloan Kettering Cancer Center
在 mskcc.org 的电子邮件经过验证
被引用次数：18991
Prostate Cancer Genomics Targeted Therapies
Pamela Pollock

Pamela Pollock

Queensland University of Technology
在 qut.edu.au 的电子邮件经过验证
被引用次数：16989
Endometrial cancer Melanoma Genomics FGFRs targeted therapies
Dieter Saur

Dieter Saur

Technical University of Munich (TUM) and German Cancer Research Center (DKFZ) …
在 tum.de 的电子邮件经过验证
被引用次数：16141
oncology pancreatic cancer targeted therapies therapy resistance tumor microenvironment
Anthony C Faber

Anthony C Faber

Virginia Commonwealth University
在 vcu.edu 的电子邮件经过验证
被引用次数：7764
targeted therapies
João T. Barata

João T. Barata

Instituto de Medicina Molecular
在 fm.ul.pt 的电子邮件经过验证
被引用次数：7153
Cancer biology Acute Lymphoblastic Leukemia Targeted therapies Signal transduction
Alshad S. Lalani

Alshad S. Lalani

VP - Translational Sciences, Zymeworks Inc.
在 zymeworks.com 的电子邮件经过验证
被引用次数：6130
Oncology R&D Cancer Biology Targeted Therapies Precision Medicine Biomarkers
1 - 10